Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Regarding Ninnion's Ischemic Stroke clinical trial timeline:

55

5 year timeline for the Ninion's, R+D and pre clinical work...

Ninnion

NIN-S119 would be the first drug of its kind in the treatment of stroke, potentially making it eligible for Breakthrough Therapy designation by the FDA, a designation that can accelerate the development timeline. IND-enabling toxicology will be completed and initial clinical trials initiated in 1Q23

Toe-may-toe Toe-mot-toe...Po-tay-toe Po-tot-o...let's call the whole thing off.

smh

M$